2010
DOI: 10.1007/s11255-010-9738-3
|View full text |Cite
|
Sign up to set email alerts
|

Unusual clinical presentation of brown tumor in hemodialysis patients: two case reports

Abstract: Brown tumor or osteoclastoma is a lytic bone tumor, which is common in secondary hyperparathyroidism (1.5-13%) in chronic dialysis patients, mainly in those with untreated renal osteodystrophy. Brown tumor appears as a result from excess osteoclast activity and consists of collections of osteoclasts intermixed with fibrous tissue and poorly mineralized woven bone. It can be manifested as a single or multiple bone lesions. Although invasive, it has no malignant potential and should be distinguished from giant c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
23
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(23 citation statements)
references
References 10 publications
0
23
0
Order By: Relevance
“…Secondary hyperparathyroidism with high BFR is a common complication of renal failure [17] which results from phosphate retention, a decline in 1,25-dihydroxyvitamin D production and consequent vitamin D receptor (VDR) activation. This necessitates the use of phosphate binders and VDR activators (VDRAs) to avoid the unfavorable effects of PTH.…”
Section: Discussionmentioning
confidence: 99%
“…Secondary hyperparathyroidism with high BFR is a common complication of renal failure [17] which results from phosphate retention, a decline in 1,25-dihydroxyvitamin D production and consequent vitamin D receptor (VDR) activation. This necessitates the use of phosphate binders and VDR activators (VDRAs) to avoid the unfavorable effects of PTH.…”
Section: Discussionmentioning
confidence: 99%
“…[1249] Multiple BT rarely is rarely found in a patient[101112] and it rarely locates in vertebra,[13] In this report, a case of a BT located in mandible and thoracal vertebra is presented with an extensive review of the literature.…”
Section: Introductionmentioning
confidence: 99%
“…It is recommended that in cases of severe or recurrent sHPT, either subtotal total PTX or early administration of calcimimetics should be considered . PTX remains an efficacious approach in resistant cases of sHPT.…”
Section: Discussionmentioning
confidence: 99%